New nanotech weapon takes aim at hard-to-treat breast cancer

Breast cancer in its various forms affects more than 250,000 Americans a year. One particularly aggressive and hard-to-treat type is triple-negative breast cancer (TNBC), which lacks specific receptors targeted by existing ...

page 2 from 25